Hypertrophic cardiomyopathy: Electrical abnormalities detected by the extended-length ECG and their relation to syncope

International Journal of Cardiology

Volumn 97, Issue 1, 2004, Pages 43-48

  Barletta, Giuseppe ^a,b   Lazzeri, Chiara ^a   Franchi, Franco ^a   Del Bene, Riccarda ^a   Michelucci, Antonio ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b 50127 ^*  (Italy)

Author keywords

Activation recovery interval; Heart rate variability; Hypertrophic cardiomyopathy; Signal averaged ECG; T wave complexity

Indexed keywords

ACCURACY; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ECG ABNORMALITY; ELECTROCARDIOGRAM; FEMALE; HEART LEFT VENTRICLE; HEART RATE; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MALE; PREDICTION; PRIORITY JOURNAL; QRS COMPLEX; QT DISPERSION; SYNCOPE; T WAVE;

ADULT; CARDIOMYOPATHY, HYPERTROPHIC; ELECTROCARDIOGRAPHY; ELECTROPHYSIOLOGY; FEMALE; HUMANS; MALE; SYNCOPE; TIME FACTORS;

EID: 4444317885     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2003.07.035     Document Type: Article

References (55)

1. Maron B.J. Hypertrophic cardiomyopathy. A systematic review. JAMA. 287:2002;1308-1320
2. McKenna W.J., Behr E.R. Hypertrophic cardiomyopathy: management, risk stratification, and prevention of sudden death. Heart. 87:2002;169-176
3. Abildskov J., Lux R. Mechanisms of simulated torsade de pointes. J. Cardiovasc. Electrophysiol. 4:1993;547
4. Michelucci A., Mortara D., Lazzeri C., Barletta G., Capalbo A., Badia T., et al. Simultaneous assessment of electrocardiographic parameters for risk stratification: validation in healthy subjects. Ital. Heart J. 3:2002;308-317
5. Klues H.G., Schiffers A., Maron B.J. Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: morphologic observations and significance as assessed by two dimensional echocardiography in 600 patients. J. Am. Coll. Cardiol. 26:1995;1699-1708
6. Hodges M., Mortara D.W. The extended-length electrocardiogram (XL-ECG). A new tool for predicting risk of sudden cardiac death. J. Electrocardiol. 32:1999;55-59
7. Task Force of the European Society of Cardiology the North American Society of Pacing Electrophysiology Heart rate variability. Standards of measurements, physiological interpretation, and clinical use. Circulation. 93:1996;1043-1065
8. Lucreziotti S., Gavazzi A., Sclesi L., Inserra C., Klersy C., Campana C., et al. Five-minute recording of heart rate variability in severe chronic heart failure: correlates with right ventricular function and prognostic implications. Am. Heart J. 139:2000;108-1095
9. de Bruyne M.C., Hoes A.W., Kors J.A., Hofman A., van Bemmel J.H., Grobbee D.E. QTc dispersion predicts cardiac mortality in the elderly: the Rotterdam Study. Circulation. 97:1998;467-472
10. Priori S.G., Mortara D.W., Napolitano C., Diehl L., Paganini V., Cantu F., et al. Evaluation of the spatial aspects of T-wave complexity in the long QT syndrome. Circulation. 96:1997;3006-3012
11. Yi G., Prasad K., Elliott P., Sharma S., Guo X., McKenna W.J., et al. T wave complexity in patients with hypertrophic cardiomyopathy. PACE. 21:1998;2382-2386
12. Lux R.L., Fuller M.S., MacLeod R.S., Ershler P.R., Punske B.B., Taccardi B. Noninvasive indices of repolarization and its dispersion. J. Electrocardiol. 32(Suppl.):1999;153-157
13. Berberi E.J. High-resolution electrocardiography. Zipes D.P., Jalife J. Cardiac electrophysiology: from cells to bedside. 3rd ed.:2000;730-737 Saunders, Philadelphia
14. Bazett J.C. An analysis of time relation of electrocardiograms. Heart. 7:1920;353-367
15. Hodges M., Salerno Q., Erlien D. Bazett's QT correction reviewed. Evidence that a linear QT correction for heart rate is better. J. Am. Coll. Cardiol. 1:1983;694
16. Brignole M., Alboni P., Benditt D., Costa S., Gaggioli G., Bottoni N., et al. Guidelines on management (diagnosis and treatment) of syncope. Eur. Heart J. 22:2001;1256-1306
17. Shamin W., Francis D.P., Yousufuddin M., Varney S., Pieopli M.F., Anker S.D., et al. Intraventricular conduction delay: a prognostic marker in chronic heart failure. Int. J. Cardiol. 70:1999;171-178
18. Silvet H., Amin J., Padmanabhan S., Pai R.G. Prognostic implications of increased QRS duration in patients with moderate and severe left ventricular systolic dysfunction. Am. J. Cardiol. 88:2001;182-185
19. Xiao H.B., Brecker S.J.D., Gibson D.G. Relative effects of left ventricular mass and conduction disturbance on activation in patients with pathological left ventricular hypertrophy. Br. Heart J. 71:1994;548-553
20. Zaidi M., Robert A., Fesler R., Dewel C., Brohet C. Dispersion of ventricular repolarization in hypertrophic cardiomyopathy. J. Electrocardiol. 29:1996;89-94
21. Zareba W., Moss A.J., Le Cessie S. Dispersion of ventricular repolarization and arrhythmic cardiac death in coronary artery disease. Am. J. Cardiol. 74:1994;550-553
22. Barr C.S., Nasas A., Freeman M., Lang C.C., Struthers A.D. QT dispersion and sudden unexpected death in chronic heart failure. Lancet. 343:1994;1423-1428
23. Glancy J.M., Garratt C.J., Woods K.L., de Bono D.P. QT dispersion and mortality after myocardial infarction. Lancet. 345:1995;945-948
24. Malik M., Batchvarov V.N. Measurements, interpretation and clinical potential of QT dispersion. J. Am. Coll. Cardiol. 36:2000;1749-1766
25. Lux R.L., Fuller M.S., MacLeod R.S., Ershler P.R., Green L.S., Taccardi B. QT dispersion: dispersion of ventricular repolarization or dispersion of QT interval? J. Electrocardiol. 30(Suppl.):1998;176-180
26. Spirito P., Bellone P., Harris K.M., Bernabò P., Bruzzi P., Maron B.J. Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy. N. Engl. J. Med. 342:2000;1778-1785
27. Millar C.K., Kralios F.A., Lux R.L. Correlation between refractory periods and AIRs from electrograms: Effects of rate and adrenergic interventions. Circulation. 72:1985;1372
28. Haws C.W., Lux R.L. Correlation between in vivo transmembrane action potential durations and activation recovery intervals from electrograms. Effects of interventions that alter repolarization time. Circulation. 81:1990;281-288
29. Burgess M.J., Baruffi S., Spaggiari S., Macchi E., Lux R., Taccardi B. Determination of activation and recovery sequences and local repolarization durations from distant electrocardiographic leads. Jpn. Heart J. 27(Suppl. 1):1986;205-216
30. Gepstein L., Hayam G., Ben-Haim S.A. Activation-repolarization coupling in the normal swine endocardium. Circulation. 96:1997;4036-4043
31. Izumida N., Asano Y., Wakimoto H., Nishiyama M., Doi S., Tsuchiya S., et al. Analysis of T wave changes by activation recovery interval in patients with atrial septal defect. Int. J. Cardiol. 74:2000;115-124
32. Wang L. QT dispersion from body surface ECG does not reflect the spatial dispersion of ventricular repolarization in sheep. Pacing Clin. Electrophysiol. 23:2000;359-364
33. Mirvis D.M. Spatial variation of QT intervals in normal persons and patients with acute myocardial infarction. J. Am. Coll. Cardiol. 5:1985;625-631
34. De Ambroggi L.D., Aime E., Ceriotti C., Rovida M., Negroni S. Mapping of ventricular repolarization potentials in patients with arrhythmogenic right ventricular dysplasia. Principal component analysis of the ST-T waves. Circulation. 96:1997;4314
35. Cripps T.R., Counihan P.J., Frenneaux M.P., Ward D.E., Camm A.J., McKenna W.J. Signal-averaged electrocardiography in hypertrophic cardiomyopathy. J. Am. Coll. Cardiol. 15:1990;956-961
36. Gavaghan T.P., Kelly R.P., Kuchar D.L., Hickie J.B., Campbell T.J. The prevalence of arrhythmias in hypertrophic cardiomyopathy: role of ambulatory monitoring and signal-averaged electrocardiography. Aust. N.Z. J. Med. 16:1986;666-670
37. Fauchier J.P., Cosnay P., Moquet B., Balleh H., Rouesnel P. Late ventricular potentials and spontaneous and induced ventricular arrhythmias in dilated or hypertrophic cardiomyopathies. A prospective study about 83 patients. Pacing Clin. Electrophysiol. 11:1988;1974-1983
38. Kuchar D.L., Thorbum C.W., Sammel N.L. Signal averaged electrocardiogram for evaluation of recurrent syncope. Am. J. Cardiol. 58:1986;949-953
39. Gang E.S., Peter T., Rosenthal M.E., Mandel W.J., Lass Y. Detection of late potentials on the surface electrocardiogram in unexplained syncope. Am. J. Cardiol. 58:1986;1014-1020
40. Winters S.L., Stewart D., Gomes J.A. Signal averaging of the surface QRS complex predicts inducibility of ventricular tachycardia in patients with syncope of unknown etiology: a prospective study. J. Am. Coll. Cardiol. 12:1988;1481-1487
41. Buxton A.E. Late potentials and syncope. El Sherif N., Turitto G. High-resolution electrocardiography. 1992;532-552 Futura Publishing, Mount Kisco, NY
42. Gregoratos G., Abrams J., Epstein A.E., et al. ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: Summary article. A report of the American College of Cardiology/American Heart Association task force on practice guidelines (ACC/AHA/NASPE committee to update the 1998 pacemaker guidelines). J. Am. Coll. Cardiol. 40:2002;1703-1719
43. McKenna W.J., Deanfield J.E., Faruqi A., England D., Oakley C.M., Goodwin J. Prognosis in hypertrophic cardiomyopathy. Role of age and clinical electrocardiographic and haemodynamic features. Am. J. Cardiol. 47:1981;532-538
44. McKenna W.J., Franklin R.C.G., Nihoyannopoulos P., Robinson K.C., Deanfield J.E. Arrhythmia and prognosis in infants, children and adolescents with hypertrophic cardiomyopathy. J. Am. Coll. Cardiol. 11:1988;147-153
45. McKenna W.J., Deanfield J.E. Hypertrophic cardiomyopathy: an important cause of sudden death. Arch. Dis. Child. 59:1984;971-975
46. Spirito P., Seidman C.E., McKenna W.J., Maron B.J. The management of hypertrophic cardiomyopathy. N. Engl. J. Med. 336:1997;775-785
47. Maron B.J. Hypertrophic cardiomyopathy. Lancet. 30:1997;127-133
48. Maron B.J., Shirani J., Poliac L.C., Mathenge R., Roberts W.C., Muller F.O. Sudden death in young competitive athletes. Clinical, demographic and pathological profiles. JAMA. 276:1996;199-204
49. McKenna W.J., Firozi S., Sharma S. Arrhythymias and sudden death in hypertrophic cardiomyopathy. Card. Electrophysiol. Rev. 6:2002;26-31
50. Watsin H.C. Multiple gene causes hypertrophic cardiomyopathy. Br. Heart J. 77(Suppl.):1994;S4-S9
51. Spirito P., Chiarella F., Carratino L., Zoni-Berisso M., Bellotti P., Vecchio C. Clinical course and prognosis of hypertrophic cardiomyopathy in an outpatients population. N. Engl. J. Med. 320:1989;749-755
52. Elliott P.M., Poloniecki J., Dickie S., Sharma S., Monserrat L., Varnava A., et al. Sudden death in hypertrophic cardiomyopathy; identification of high risk patients. J. Am. Coll. Cardiol. 36:2000;2212-2218
53. Maron B.J., Shen W.K., Link M.S., Epstein A.E., Almquist A.K., Daubert J.P., et al. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. N. Engl. J. Med. 342:2000;365-373
54. Elliott P.M., Gimero Blanes J.R., Mahon N.G., Poloniecki J.D., McKenna W.J. Relation between severity of left ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy. Lancet. 357:2001;420-424
55. Devereux R.B., Alonso D.R., Lutas E.M., Gottlieb G.J., Campo E., Sachs I., et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am. J. Cardiol. 57:1986;450-458